GLG News by Ophthalmologists

PDT remains a viable option for patients with new blood vessels from high myopia. Despite the era of antivegf therapy PDT may be safer in these patients than repeated injection. This article yet again defies another area for the use of PDT. PDT will be continued to be complemented to the currently available...

This article refers to an implanted glaucoma device that eliminates bleb formation for filtration. Blebs are fragile and represent a source for infection.  

Firstly, the sample group of 49 cases is too small. Also the surgical complications are higher with ac replacements, these eyes usually have poor anatomic arrangements which necessitated the ac lens in the first place, so surgeons are less likely to go back into these eyes. Statistically there are many...

The early results of a new corneal inlay (PresbyLens, ReVision Optics) are presented.  A corneal inlay is placed underneath a LASIK corneal flap in the non-dominant eye to correct presbyopia.  This version of a corneal inlay is 1.5mm in diameter.  The outcomes of 15 patients showed good...

The recent approval of the aspheric version of the Restor multifocal intraocular lens is positive as most surgeons already understand the value of aspheric optics.  As shown with monofocal aspheric lenses, such as the Alcon IQ, Advanced Medical Optics' Tecnis, and Bausch and Lomb's Sofport, aspheric...

The article describes some of the legal concerns in billing for presbyopia-correcting IOLs.  The ruling by the CMS (Centers for Medicaid and Medicare Services) in 2005 that essentially allowed surgeons to charge patients an additional out-of-pocket cost related to the implantation of these lenses...

The Phase III Trials of Xibrom showed excellent efficacy in the treatment of post cataract surgery pain and inflammation.  The trial involved 500 cataract patients and is important in that it demonstrates that a once-a-day formulation is effacacious in treating patients post-operatively. ...

Glaucoma is an elusive diagnostic dilemma.  The aim of treatment is to lower the intraocular pressure below 18 mm of mercury.However in the practice of ophthalmology a single reading on the quarterly exam fails to demonstrate the fluctuations of pressure thatmay cause optic nerve damage in the...

The Center for Medicare and Medicaid Services (CMS) has ruled that beneficiaries may pay out of pocket for additional non-covered services related to presbyopia and astigmatism correcting intraocular lenses (IOLs) that are provided by surgeons and facilities (such as Ambulatory Surgery Centers and Hospital...

This lay article proves again that lawyers are actively pursuing litigation in this profitable field.  Given that over 1 million people per year have this surgery, and physicians are under constant pressure to increase patient volumes, it is a potentially dangerous combination. ...